425 related articles for article (PubMed ID: 18635336)
1. Inhibition of inflammatory mediator secretion by (-)-DHMEQ in mouse bone marrow-derived macrophages.
Suzuki E; Sugiyama C; Umezawa K
Biomed Pharmacother; 2009 Jun; 63(5):351-8. PubMed ID: 18635336
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of macrophage activation and phagocytosis by a novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin.
Suzuki E; Umezawa K
Biomed Pharmacother; 2006 Nov; 60(9):578-86. PubMed ID: 16978829
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of inflammatory cytokine secretion from mouse microglia cells by DHMEQ, an NF-kappaB inhibitor.
Takatsuna H; Morita S; Nagatsu T; Sawada M; Umezawa K
Biomed Pharmacother; 2005 Jul; 59(6):318-22. PubMed ID: 15932789
[TBL] [Abstract][Full Text] [Related]
5. Induction of histidine decarboxylase in macrophages inhibited by the novel NF-kappaB inhibitor (-)-DHMEQ.
Suzuki E; Ninomiya Y; Umezawa K
Biochem Biophys Res Commun; 2009 Feb; 379(2):379-83. PubMed ID: 19103154
[TBL] [Abstract][Full Text] [Related]
6. Bis-(3-hydroxyphenyl) diselenide inhibits LPS-stimulated iNOS and COX-2 expression in RAW 264.7 macrophage cells through the NF-kappaB inactivation.
Shin KM; Shen L; Park SJ; Jeong JH; Lee KT
J Pharm Pharmacol; 2009 Apr; 61(4):479-86. PubMed ID: 19298695
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory activity of 4-methoxyhonokiol is a function of the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-kappaB, JNK and p38 MAPK inactivation.
Zhou HY; Shin EM; Guo LY; Youn UJ; Bae K; Kang SS; Zou LB; Kim YS
Eur J Pharmacol; 2008 May; 586(1-3):340-9. PubMed ID: 18378223
[TBL] [Abstract][Full Text] [Related]
8. A phenolic acid phenethyl urea compound inhibits lipopolysaccharide-induced production of nitric oxide and pro-inflammatory cytokines in cell culture.
Hwang JM; Yu JY; Jang YO; Kim BT; Hwang KJ; Jeon YM; Lee JC
Int Immunopharmacol; 2010 Apr; 10(4):526-32. PubMed ID: 20138247
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of lipopolysaccharide-inducible nitric oxide synthase and IL-1beta through suppression of NF-kappaB activation by 3-(1'-1'-dimethyl-allyl)-6-hydroxy-7-methoxy-coumarin isolated from Ruta graveolens L.
Raghav SK; Gupta B; Shrivastava A; Das HR
Eur J Pharmacol; 2007 Mar; 560(1):69-80. PubMed ID: 17292351
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effect of allylpyrocatechol in LPS-induced macrophages is mediated by suppression of iNOS and COX-2 via the NF-kappaB pathway.
Sarkar D; Saha P; Gamre S; Bhattacharjee S; Hariharan C; Ganguly S; Sen R; Mandal G; Chattopadhyay S; Majumdar S; Chatterjee M
Int Immunopharmacol; 2008 Sep; 8(9):1264-71. PubMed ID: 18602073
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory activity of 21(alpha, beta)-methylmelianodiols, novel compounds from Poncirus trifoliata Rafinesque.
Zhou HY; Shin EM; Guo LY; Zou LB; Xu GH; Lee SH; Ze KR; Kim EK; Kang SS; Kim YS
Eur J Pharmacol; 2007 Oct; 572(2-3):239-48. PubMed ID: 17662711
[TBL] [Abstract][Full Text] [Related]
12. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of lipopolysaccharide-induced iNOS and COX-2 expression by dehydroevodiamine through suppression of NF-kappaB activation in RAW 264.7 macrophages.
Noh EJ; Ahn KS; Shin EM; Jung SH; Kim YS
Life Sci; 2006 Jul; 79(7):695-701. PubMed ID: 16554073
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory activities of ent-16alphaH,17-hydroxy-kauran-19-oic acid isolated from the roots of Siegesbeckia pubescens are due to the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-kappaB inactivation.
Park HJ; Kim IT; Won JH; Jeong SH; Park EY; Nam JH; Choi J; Lee KT
Eur J Pharmacol; 2007 Mar; 558(1-3):185-93. PubMed ID: 17207792
[TBL] [Abstract][Full Text] [Related]
15. Acacetin suppressed LPS-induced up-expression of iNOS and COX-2 in murine macrophages and TPA-induced tumor promotion in mice.
Pan MH; Lai CS; Wang YJ; Ho CT
Biochem Pharmacol; 2006 Nov; 72(10):1293-303. PubMed ID: 16949556
[TBL] [Abstract][Full Text] [Related]
16. Fermented guava leaf extract inhibits LPS-induced COX-2 and iNOS expression in Mouse macrophage cells by inhibition of transcription factor NF-kappaB.
Choi SY; Hwang JH; Park SY; Jin YJ; Ko HC; Moon SW; Kim SJ
Phytother Res; 2008 Aug; 22(8):1030-4. PubMed ID: 18618521
[TBL] [Abstract][Full Text] [Related]
17. Diarctigenin, a lignan constituent from Arctium lappa, down-regulated zymosan-induced transcription of inflammatory genes through suppression of DNA binding ability of nuclear factor-kappaB in macrophages.
Kim BH; Hong SS; Kwon SW; Lee HY; Sung H; Lee IJ; Hwang BY; Song S; Lee CK; Chung D; Ahn B; Nam SY; Han SB; Kim Y
J Pharmacol Exp Ther; 2008 Nov; 327(2):393-401. PubMed ID: 18694995
[TBL] [Abstract][Full Text] [Related]
18. Effect of 5-O-Methylhirsutanonol on nuclear factor-kappaB-dependent production of NO and expression of iNOS in lipopolysaccharide-induced RAW264.7 cells.
Han JM; Lee WS; Kim JR; Son J; Kwon OH; Lee HJ; Lee JJ; Jeong TS
J Agric Food Chem; 2008 Jan; 56(1):92-8. PubMed ID: 18069795
[TBL] [Abstract][Full Text] [Related]
19. 4-O-Methylgallic acid suppresses inflammation-associated gene expression by inhibition of redox-based NF-kappaB activation.
Na HJ; Lee G; Oh HY; Jeon KS; Kwon HJ; Ha KS; Lee H; Kwon YG; Kim YM
Int Immunopharmacol; 2006 Oct; 6(10):1597-608. PubMed ID: 16919832
[TBL] [Abstract][Full Text] [Related]
20. Nafamostat mesilate suppresses NF-kappaB activation and NO overproduction in LPS-treated macrophages.
Noguchi S; Nakatsuka M; Konishi H; Kamada Y; Chekir C; Kudo T
Int Immunopharmacol; 2003 Sep; 3(9):1335-44. PubMed ID: 12890431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
